jollibee app NonePutin says Russia attacked Ukraine with a new missile that he claims the West can't stopBruins see improvements under new coach, tackle Canucks next

NoneMeet Jalen Redmond, the undrafted free agent carving out a niche with the VikingsThe Johnstown Tomahawks hope to reboot a lengthy homestand Friday and Saturday at 1st Summit Arena @ Cambria County War Memorial. A 10-game stretch at the War Memorial began with a pair of disappointing losses to the first-place Rochester Jr. Americans this past weekend. An opportunity to close the gap in the North American Hockey League East Division standings slipped away in those two setbacks, but an opportunity to reverse the trend await sixth-place Johnstown. Tenth-place Danbury Hat Tricks, with a revamped lineup, visit for a two-game set. Face-off is set for 7:30 p.m. Friday and 7 p.m. Saturday. "I really liked this week's practice," Tomahawks coach Jared Kersner said. "We had a good attention to detail, a good effort. We had just played four games – two against Maryland, and we split those; and two against Rochester, who unfortunately, beat us both times, but both were one-shot games. We were right there. "Our special teams weren't where they've been in November, and there were some small, small details and issues that made the difference," Kersner added. "On Friday night, we had a 3-on-2 (rush). They countered back and scored a game-winning goal with 3 1/2 minutes left. Then (on Saturday), at the end of the second period, they scored with one minute to go, and we took a penalty with two seconds to go. They started the next period and scored on the power play. "Those tiny details. There are things we could have done a little better. When you're playing a first-place team, that's what happens." Danbury (9-14-2) has won two straight games and will bring some momentum to Johnstown (13-12-2). The Hat Tricks swept the host New Hampshire Mountain Kings Dec. 6 and 7, as recently acquired Andrew Gibbons scored seven goals, with four coming in a 6-2 win Dec. 6 and three more in a 10-5 victory Saturday. Ironically, Gibbons had gone 16 games without scoring a goal after opening the season on a five-game, goal-scoring streak. He played 21 games with Rochester before joining Danbury this past week. His overall point total (18) ranks third on the team. Niko Tournas leads Danbury with 15 goals and 28 points. Another newcomer, Alexis Billequey, has 20 points, including eight goals. Billequey played 21 games with the Elmira Aviators before joining Danbury this past weekend to collect six assists in two contests. "They made a lot of moves the last two weeks to improve their roster," Kersner said. "That was Gibbons' first weekend with the team. A new home for him. Same with Billequey, a new acquisition in a trade. They're a team that has struggled at times, but they have revamped their roster with a bunch of moves." Goaltender Jack Fialkoff is 5-8-1, with a 3.97 goals against average and .893 save percentage. The Tomahawks' Ryan Flaherty has a team-high 12 goals and is tied for the team lead with 21 points. Caden Olenczak has 18 assists and 21 points. The balanced Tomahawks have three other 20-point scorers in Sam Blanton (7-13-20), Adam Ondris (13-7-20) and Cullen Emery (6-14-20). Goaltender Zack Ferris is 10-4-0 with a 3.12 goals against average and .915 save percentage. "It's important for us to focus on ourselves first," Kersner said. "I don't think we had a good weekend last week. We want to get back to what made us successful." (c)2024 The Tribune-Democrat (Johnstown, Pa.) Visit The Tribune-Democrat (Johnstown, Pa.) at www.tribune-democrat.com Distributed by Tribune Content Agency, LLC.Scheffler goes on a run of birdies in the Bahamas and leads by 2

HSFTOOLS Expands the Thermal Imaging Market with a Focus on Practical Applications

JuJu Watkins scores 21, No. 6 USC downs Oregon 66-53 in Big Ten opener( MENAFN - EIN Presswire) Clinical Research Organization Global market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 13, 2024 /EINPresswire / -- The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only! The Clinical Research Organization CRO market has been growing solidly in recent times. An industry forecast indicates an increase from $54.15 billion in 2023 to $59.41 billion in 2024 at a potent compound annual growth rate CAGR of 9.7%. This favorable progression during the historic period is chiefly attributed to factors like an aging global population, mounting prevalence of chronic conditions, globalization of clinical trials, a greater focus on orphan drug development, along with substantial government funding and grants. What Is the Future Outlook and Market Size for Clinical Research Organizations? The Clinical Research Organization market is forecasted to witness robust growth in the upcoming years. According to data projections, by 2028, the market will hit a staggering figure of $86.33 billion, with a compound annual growth rate CAGR at 9.8%. The primary factors driving growth throughout the forecasted period include shifting focus towards personalized medicine, an upsurge in clinical trials, expanding drug development pipelines, increased spending on pharmaceutical research and development, and the rising boom in biopharmaceuticals. Discover Key Insights and Market Trends with a Free Sample Report of the Global Clinical Research Organization Market: What Are the Key Market Drivers Catalyzing Growth in the CRO Market? A key driver instigating this growth trajectory is the burgeoning demand for personalized medicine. Personalized medicine, also known as precision medicine or individualized medicine, is an innovative approach to medical care that customizes treatments and interventions based on the unique characteristics of each patient. Due advancements in genomics and biotechnology, treatments have become more targeted and effective, catering specifically to individual genetic profiles and health conditions. CROs play a crucial role in personalized medicine by carrying out specialized trials and analyses to tailor treatments to individual genetic and biological profiles. For instance, the Personalized Medicine Coalition, a US-based non-profit organization, reports that the FDA approved 16 novel personalized therapies for rare disease patients in 2023 alone, a steep rise from the six approved in 2022. Therefore, the increasing demand for personalized medicine is substantially driving the growth of the clinical research organization market. Pre-book the report for a swift delivery: Which Industry Giants Are Powering the Clinical Research Organization Market? Major companies operating in the CRO market include Laboratory Corporation of America Holdings, IQVIA Holdings Inc., PPD Inc., ICON plc, Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Medpace Holdings Inc., Almac Group Ltd., Premier Research Group Limited, and others. These corporations have been instrumental in driving the robust growth of the clinical research market. What Noteworthy Trends Are Shaping the Future of the Clinical Research Organization Market? Emerging trends highlight that corporations in the clinical research organization market are increasingly exploring advanced solutions such as artificial intelligence AI-driven end-to-end data platforms. These platforms enhance data integration, analysis, thereby revolutionizing overall trial efficiency. For instance, Elligo Health Research Inc., a US-based clinical research organization, unveiled DataAI Connect in January 2023, a breakthrough data and technology platform engineered to expedite data-driven clinical research. How Is the Global Clinical Research Organization Market Segmented? The clinical research organization market exhibits the following key segments: 1 By Service: Drug Discovery Services, Pre-Clinical Services, Clinical Services, Post Approval Services 2 By Production: In-house, Outsourced 3 By Indication: Oncology, Central Nervous System, Cardiovascular Diseases, Metabolic Disorders, Immunology, Respiratory, Musculoskeletal Disorders, Hematological Disorders 4 By End User: Pharmaceutical And Biotechnology Companies, Medical Device Companies, Governments And Private Firms, Academic Institutions, Other End Users How Is the Clinical Research Organization Market Performing Globally? North America was the largest region in the clinical research organization market in 2023, but the Asia-Pacific region is set to surpass in the near future as the fastest-growing region during the forecasted period. The regions assessed in the clinical research organization market report span Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Browse more similar reports- Virtual Clinical Trials Global Market Report 2024 eClinical Solutions Global Market Report 2024 Electronic Clinical Outcome Assessment Solutions Global Market Report 2024 About The Business Research Company Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game. Contact us at: The Business Research Company: Americas +1 3156230293 Asia +44 2071930708 Europe +44 2071930708 Email us at ... Follow us on: LinkedIn: YouTube: Global Market Model: global-market-model Oliver Guirdham The Business Research Company +44 20 7193 0708 email us here Visit us on social media: Facebook X LinkedIn Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. MENAFN12122024003118003196ID1108988704 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Ruben Amorim urges Man Utd to ‘run like mad dogs’ in bid to turn season round